Priority Date: 29.11.11 (US 201161629827P)

HETEROCYCLIC AMIDES COMPOUNDS WHICH ARE HDAC6 INHIBITORS AND USED AS ANTI-TUMORAL AGENTS

  • Application ID: EP12854213
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 11 - 50 employees
Company dna cabinet laurent and charras
no operation time available
Headquarter in Lyon and 5 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 29.11.2011 - Priority Date (US 201161629827P)
  • 06.06.2013 - Publication A1 (WO2013078544)
  • 08.10.2014 - Publication A1 (EP2785720)